Last reviewed · How we verify

NCT06781229: OROBESITE

Periodontal Microbiota of Patients Candidates for Bariatric Surgery with Body Mass Index Greater Than 30

Not yet recruiting Last updated 17 January 2025
What this trial tests

trial in Bariatric Surgery in 170 participants. Not yet recruiting.

Timeline
1 March 2025
Primary endpoint
1 March 2029
1 March 2029

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment170
Start date1 March 2025
Primary completion1 March 2029
Estimated completion1 March 2029

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Bariatric Surgery or Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare the microbiological composition of the periodontal plaque of obese people undergoing bariatric surgery according to their Body Mass Index. The main question it aims to answer is: Does obese patients have different microbiote according to their obesity? Obesity being classified in two groups : * group "obesity" for a BMI between 30 and 35 * versus "morbid obesity" group with a BMIabove 35. Participants who are scheduled to undergo bariatric surgery as part of their regular medical care will answer questions about their quality of life, hygiene habits, and saliva and periodontal samples will be taken.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bariatric Surgery

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06781229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing